UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immune checkpoint inhibitor-related colitis assessment and prognosis: can IBD scoring point the way?

British journal of cancer, 2020-07, Vol.123 (2), p.207-215

2020

Volltextzugriff (PDF)

The Type 1 Insulin-Like Growth Factor Receptor Pathway

Clinical cancer research, 2008-10, Vol.14 (20), p.6364-6370

2008

Volltextzugriff (PDF)

Type 1 Insulin-like Growth Factor Receptor Translocates to the Nucleus of Human Tumor Cells

Cancer research (Chicago, Ill.), 2010-08, Vol.70 (16), p.6412-6419

2010

Volltextzugriff (PDF)

RAPTOR up-regulation contributes to resistance of renal cancer cells to PI3K-mTOR inhibition

PloS one, 2018-02, Vol.13 (2), p.e0191890-e0191890

2018

Volltextzugriff (PDF)

Abiraterone acetate in combination with prednisone in the treatment of metastatic hormone-sensitive prostate cancer: clinical evidence and experience

Therapeutic Advances in Urology, 2019, Vol.11, p.1756287218820804-1756287218820804

2019

Volltextzugriff (PDF)

Depletion of the type 1 IGF receptor delays repair of radiation-induced DNA double strand breaks

Radiotherapy and oncology, 2012-06, Vol.103 (3), p.402-409

2012

Volltextzugriff (PDF)

PemBla: A Phase 1 study of intravesical pembrolizumab in recurrent non‐muscle‐invasive bladder cancer

BJUI compass, 2023-05, Vol.4 (3), p.322-330

2023

Volltextzugriff (PDF)

Re: Pembrolizumab for Treatment-refractory Metastatic Castration-resistant Prostate Cancer: Multicohort, Open-label Phase II KEYNOTE-199 Study

European urology, 2020-06, Vol.77 (6), p.759-760

2020

Volltextzugriff (PDF)

Validation of the type 1 insulin-like growth factor receptor as a therapeutic target in renal cancer

Molecular cancer therapeutics, 2009-06, Vol.8 (6), p.1448-1459

2009

Volltextzugriff (PDF)

Development of a best-practice clinical guideline for the use of bleomycin in the treatment of germ cell tumours in the UK

British journal of cancer, 2018-10, Vol.119 (9), p.1044-1051

2018

Volltextzugriff (PDF)

Randomized Phase II Study Investigating Pazopanib Versus Weekly Paclitaxel in Relapsed or Progressive Urothelial Cancer

Journal of clinical oncology, 2017-06, Vol.35 (16), p.1770-1777

2017

Volltextzugriff (PDF)

Bilateral Testicular Germ Cell Tumors: A Case-Series From a UK-Based Tertiary Referral Center Over 19 Years

Clinical genitourinary cancer, 2018-06, Vol.16 (3), p.e513-e516

2018

Volltextzugriff (PDF)

Cardiopulmonary resuscitation discussions with patients admitted to acute oncology wards: A national audit of current practice

European journal of cancer care, 2020-05, Vol.29 (3), p.e13218-n/a

2020

Volltextzugriff (PDF)

Changing Practice Evaluation—Stage 1 Seminoma: Outcomes With Adjuvant Treatment Versus Surveillance: Risk Factors for Recurrence and Optimizing Follow-up Protocols—Experience From a Supraregional Center

Clinical genitourinary cancer, 2018-06, Vol.16 (3), p.240-244

2018

Volltextzugriff (PDF)

Testicular cancer in men with undescended testis: Insights from the Thames Valley Testicular Cancer database

Journal of clinical urology, 2019-07, Vol.12 (4), p.274-279

2019

Volltextzugriff (PDF)

Systemic chemotherapy for patients with bladder cancer – current controversies and future directions

Cancer treatment reviews, 2004-06, Vol.30 (4), p.343-358

2004

Volltextzugriff (PDF)

IGF-1R inhibition enhances radiosensitivity and delays double-strand break repair by both non-homologous end-joining and homologous recombination

Oncogene, 2014-11, Vol.33 (45), p.5262-5273

2014

Volltextzugriff (PDF)

Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol

The Lancet (British edition), 2022-01, Vol.399 (10323), p.447-460

2022

Volltextzugriff (PDF)

Prednisolone or Pentoxifylline for Alcoholic Hepatitis

The New England journal of medicine, 2015-04, Vol.372 (17), p.1619-1628

2015

Volltextzugriff (PDF)

Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial

The lancet oncology, 2015-01, Vol.16 (1), p.76-86

2015

Volltextzugriff (PDF)

Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol

The lancet oncology, 2023-05, Vol.24 (5), p.443-456

2023

Volltextzugriff (PDF)

Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma

Nature communications, 2024-07, Vol.15 (1), p.5935-14, Article 5935

2024

Volltextzugriff (PDF)

Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer: A National COVID Cancer Cross-sectional Evaluation

JAMA oncology, 2023-02, Vol.9 (2), p.188

2023

Volltextzugriff (PDF)

Persistence of clonal T-cell expansions following high-dose chemotherapy and autologous peripheral blood progenitor cell rescue

British journal of haematology, 2000-12, Vol.111 (3), p.766-773

2000

Volltextzugriff (PDF)

1 – 25 von 185

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(176)
Mit Volltextzugriff
(163)

Publikationsform

Sprache

Englisch
(185)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Immune checkpoint inhibitor-related colitis assessment and prognosis: can IBD scoring point the way?

The Type 1 Insulin-Like Growth Factor Receptor Pathway

Type 1 Insulin-like Growth Factor Receptor Translocates to the Nucleus of Human Tumor Cells

RAPTOR up-regulation contributes to resistance of renal cancer cells to PI3K-mTOR inhibition

Abiraterone acetate in combination with prednisone in the treatment of metastatic hormone-sensitive prostate cancer: clinical evidence and experience

Depletion of the type 1 IGF receptor delays repair of radiation-induced DNA double strand breaks

PemBla: A Phase 1 study of intravesical pembrolizumab in recurrent non‐muscle‐invasive bladder cancer

Re: Pembrolizumab for Treatment-refractory Metastatic Castration-resistant Prostate Cancer: Multicohort, Open-label Phase II KEYNOTE-199 Study

Validation of the type 1 insulin-like growth factor receptor as a therapeutic target in renal cancer

Development of a best-practice clinical guideline for the use of bleomycin in the treatment of germ cell tumours in the UK

Randomized Phase II Study Investigating Pazopanib Versus Weekly Paclitaxel in Relapsed or Progressive Urothelial Cancer

Bilateral Testicular Germ Cell Tumors: A Case-Series From a UK-Based Tertiary Referral Center Over 19 Years

Cardiopulmonary resuscitation discussions with patients admitted to acute oncology wards: A national audit of current practice

Changing Practice Evaluation—Stage 1 Seminoma: Outcomes With Adjuvant Treatment Versus Surveillance: Risk Factors for Recurrence and Optimizing Follow-up Protocols—Experience From a Supraregional Center

Testicular cancer in men with undescended testis: Insights from the Thames Valley Testicular Cancer database

Systemic chemotherapy for patients with bladder cancer – current controversies and future directions

IGF-1R inhibition enhances radiosensitivity and delays double-strand break repair by both non-homologous end-joining and homologous recombination

Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol

Prednisolone or Pentoxifylline for Alcoholic Hepatitis

Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial

Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol

Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma

Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial

Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer: A National COVID Cancer Cross-sectional Evaluation

Persistence of clonal T-cell expansions following high-dose chemotherapy and autologous peripheral blood progenitor cell rescue

Suchergebnisse filtern